Omar Shaltout: When Hematology Meets Gastroenterology in the ICU
Omar Shaltout, ICU Resident at Elkheer Hospital, shared on LinkedIn:
”When Hematology Meets Gastroenterology in the ICU:
A Catchy Case of Budd–Chiari Syndrome With Factor V Leiden Complicated by HRS
A 42-year-old female was admitted in a critical condition with progressive abdominal distension, hypotension, and worsening renal function.
Initial assessment showed a picture of advanced portal hypertension with tense ascites.
Ascitic fluid analysis revealed a high SAAG, confirming a portal hypertensive process.
Renal parameters were already deteriorating, raising early concern for hepatorenal physiology.
Imaging became the turning point.
Abdominal ultrasound and subsequent MRV confirmed acute thrombosis of all three hepatic veins, establishing the diagnosis of Budd–Chiari Syndrome.
The key clinical question was not the diagnosis itself, but the cause.
A comprehensive thrombophilia workup revealed a Factor V Leiden mutation (heterozygous), while secondary causes such as antiphospholipid syndrome and myeloproliferative disorders were excluded.
This finding explained the extensive hepatic venous thrombosis and reframed the case as a hematology-driven GI emergency.
Despite supportive management, the patient progressed into hepatorenal syndrome, with:
- Rapidly rising creatinine (peaking at 4.8 mg/dL)
- Severe hyponatremia
- Hypotension and metabolic derangement
Management became a delicate balance between:
- The need for lifelong anticoagulation due to inherited thrombophilia
- And the presence of significant liver-related coagulopathy and portal hypertension
This case highlighted how Budd–Chiari syndrome is never purely a hepatic disease.
It sits at the intersection of hematology, gastroenterology, nephrology, and critical care, where early recognition and timely escalation can be lifesaving.
Given the severity of portal hypertension and progressive HRS, urgent TIPS consideration with early liver transplant evaluation was recommended.”
Stay updated with Hemostasis Today.
-
Mar 10, 2026, 14:33Eugene Tang: A Look at What’s Happening in Life After Stroke Research Across Europe at ELASF 2026
-
Mar 10, 2026, 14:25Ahd Elmahi: Complex Case of Catecholamine-Induced Multiorgan Failure and Arterial Thrombosis in Community-Acquired Pneumonia
-
Mar 10, 2026, 13:36Nirupama Yechoor: How Survivors of Stroke Define Spiritual Wellbeing in Recovery
-
Mar 10, 2026, 13:17Jeannie Devereaux: A Novel Technique for Precise High-Dose PRP Injection in Hip Labral Tear
-
Mar 10, 2026, 13:13Wolfgang Miesbach: Highlighting a Critical and Overlooked Dimension of Rare Bleeding Disorders in Women at EAHAD 2026
-
Mar 10, 2026, 13:08Michael Ertl: Honoured To Be Elected Fellow of the European Stroke Organisation
-
Mar 10, 2026, 13:00Nita Radhakrishnan: Benchmarking Hemophilia Care Across Global Income Settings Using Data from India
-
Mar 10, 2026, 12:59Hisam Siddiqi: Night Sweats Are Not Always a Hematological Plot Twist
-
Mar 10, 2026, 12:54Tzu-Fei Wang: Reassuring Real-World Data for Clinicians to Guide Anticoagulation in Prostate Cancer